Portfolio

Open Monoclonal Technology

Builds the first platform for generating human monoclonal antibodies using a transgenic rat

  • Palo Alto, CA

  • Contact:
    Ron Eastman
  • Acquired by: Ligand Pharmaceuticals
  • Exit date: December 11, 2015
  • Logo

Related News

All content © 2022
Legal Disclaimer | Privacy Notice

Website by Eric Miller Design